Skip to content

Public FDA record

Z-0271-2023: K-ASSAY IgA Immunoturbidimetric Assay, REF: KAI-013

Recall record Z-0271-2023 for Kamiya Biomedical Company, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0271-2023
Company in FDA record
Kamiya Biomedical Company, LLC
FDA classification date
Nov 21, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

IgA Reagent may start showing cloudiness over time, which can affect assay performance.

Source facts

Action
On 9/28/22, recall notices were sent to customers informing them to stop using affected kit lots and to return complete and partially used kits to the recalling firm. Further, if opaque turbidity is observed, or the controls of the affected assay are not within range, do not report the test results. Distributors are asked to contact their customers and to inform them of the recall. Alternately, distributors can send the recalling firm their customer list so the recalling firm can notify the customers directly. Complete and return the customer acknowledgement. The following firm contacts were provided: (206) 575-8068 and quality@k-assay.com
Initiated
2022-09-28
Root cause
Under Investigation by firm
Distribution
Worldwide - US Nationwide distribution in the states of FL, NC, TX, TN, PA, CA, NY, IL, MA and the country of Czech Republic.
Recall number
Z-0271-2023
Recall status
Open, Classified
CDRH record ID
196551
FDA classified
2022-11-21
Recall event number
91030

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗